Breast, ovarian, pancreative, and prostate cancer have been added to the National Comprehensive Cancer Network Genetic/Familial High-Risk Assessment Guidelines following a recent expansion that includes colorectal, endometrial, and gastric cancers. This expansion of tumor types reflects the latest advancements in genetic research and offers life-saving insights for those with cancer and those with a family history of cancer. This development reinforces the critical importance of genetic counseling and testing as a path to screening, prevention, and potentially targeted therapies.
If you have one of these cancers or have family members impacted by them, we urge you to talk with a genetic counselor. Genetic testing is empowering because it helps you understand your risk and empowers you to make more informed healthcare decisions that promise an improved outcome.
Knowledge truly is power.
